Screening study for genetic polymorphisms affecting pharmacokinetics of pioglitazone
نویسندگان
چکیده
Ji Young Yun, Bo-Hyung Kim, Ji Hyun Lee, Kidong Lee, KyuBum Kwack and Sung-Vin Yim* Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, Seoul 02447, Korea, Department of BioMedical Science, College of Life Science, CHA University, SeongNam 13496, Republic of Korea *Correspondence: S-V. Yim; Tel: +82-2-958-9567, Fax: +82-2-958-9559, E-mail: [email protected], K. B. Kwack; Tel: +82-01-4416-3704, E-mail: [email protected]
منابع مشابه
Plasma pharmacokinetics of pioglitazone following oral or intravenous administration in Holstein cows
Pioglitazone belongs to the thiazolidinedione (TZD) class of antidiabetic agents, with proven efficacy in increasing insulin sensitivity and in the treatment of type 2 diabetes mellitus in humans. Pioglitazone has been proposed as a potential feed additive to reduce insulin resistance and consequently some of the metabolic disorders in transition cows. This study was aimed at determining the ph...
متن کاملGenotypes Affecting the Pharmacokinetics of Anticancer Drugs
Cancer treatment is becoming more and more individually based as a result of the large inter-individual differences that exist in treatment outcome and toxicity when patients are treated using population-based drug doses. Polymorphisms in genes encoding drug-metabolizing enzymes and transporters can significantly influence uptake, metabolism, and elimination of anticancer drugs. As a result, th...
متن کاملCurrent clinical evidence on pioglitazone pharmacogenomics
Pioglitazone is the most widely used thiazolidinedione and acts as an insulin-sensitizer through activation of the Peroxisome Proliferator-Activated Receptor-γ (PPARγ). Pioglitazone is approved for use in the management of type 2 diabetes mellitus (T2DM), but its use in other therapeutic areas is increasing due to pleiotropic effects. In this hypothesis article, the current clinical evidence on...
متن کاملTrimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone.
We studied the effects of the CYP2C8 inhibitor trimethoprim and CYP2C8 genotype on the pharmacokinetics of the antidiabetic pioglitazone. In a randomized crossover study, 16 healthy volunteers with the CYP2C8(*)1/(*)1 (n = 8), (*)1/(*)3 (n = 5), or (*)3/(*)3 (n = 3) genotype ingested 160 mg of trimethoprim or placebo twice daily for 6 days. On day 3, they ingested 15 mg of pioglitazone. The eff...
متن کاملScreening of LEP gene polymorphisms as a risk factor for obesity and type 2 diabetes in Iraqis
The prevalence of obesity and diabetes changes dramatically with lifestyle and unequal risk among individuals have made scientists interested to understand how the environment interferes with genetic factors to make it so-called genetic predisposition. This study aimed to explore wherethe most variable region is in leptin gene and analyse microsatellite repeats with direct sequencing in Iraqis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016